About Tempus AI, Inc.
Tempus AI, Inc. is a United States–based precision medicine technology company that leverages artificial intelligence, genomic sequencing, and clinical data analytics to advance personalized healthcare. The company provides an AI-enabled platform that integrates molecular, clinical, imaging, and real-world data to support physicians, researchers, and life sciences organizations in making data-driven treatment decisions. Its offerings include next-generation sequencing (NGS) diagnostics, oncology and cardiology testing, clinical trial matching, companion diagnostics, biomarker discovery, healthcare analytics, and AI-powered decision support solutions. Tempus AI also partners with pharmaceutical, biotechnology, healthcare provider, and academic research organizations to accelerate drug development, clinical research, and precision medicine initiatives. Founded in 2015, the company is headquartered in Chicago, Illinois, United States.